Transaction DateRecipientSharesTypePriceValue
24th September 2020Randal J Kirk21,428Grant/award etc.$3.50$74,998.00
12th August 2020Randal J Kirk10,779Open or private purchase$4.26$45,918.54
12th August 2020Randal J Kirk10,775Open or private purchase$4.26$45,901.50
12th August 2020Randal J Kirk30,514Open or private purchase$4.26$129,989.64
12th August 2020Randal J Kirk29,652Open or private purchase$4.26$126,317.52
12th August 2020Randal J Kirk8,952Open or private purchase$4.26$38,135.52
12th August 2020Randal J Kirk278,921Open or private purchase$4.26$1,188,203.46
12th August 2020Randal J Kirk1,664Open or private purchase$4.26$7,088.64
12th August 2020Randal J Kirk1,993Open or private purchase$4.26$8,490.18
12th August 2020Randal J Kirk10,792Open or private purchase$4.26$45,973.92
Histogenics logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 3/10.

Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. The company was founded on June 28, 2000 and is headquartered in Waltham, MA.

Ticker: HSGX
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1372299
Employees: 49
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Cash at Carrying Value: $15 M (0%)
Assets, Current: $23 M (45%)
Property, Plant and Equipment, Net: $232 Th (4%)
Other Assets, Noncurrent: $483 Th (-27%)
Assets: $24 M (41%)
Accounts Payable, Current: $508 Th (-73%)
Accrued Liabilities, Current: $2 M (0%)
Liabilities, Current: $7 M (54%)
Long-term Debt, Excluding Current Maturities: $2 M (88%)
Other Liabilities, Noncurrent: $0 (-100%)
Liabilities: $9 M (57%)
Common Stock, Value, Issued: $1 M (156%)
Common Stock, Shares, Issued: $135 M (156%)
Retained Earnings (Accumulated Deficit): $59 M (0%)
Treasury Stock, Value: $479 Th (0%)
Stockholders' Equity (Parent): $15 M (0%)
Liabilities and Equity: $24 M (41%)
General and Administrative Expenses: $2 M (-56%)
Operating Income/Loss: $3 M (-53%)
Other Income, net: $248 Th (-5%)